Low Prevalence of Antigliadin and Anti-Endomysium Antibodies in Subclinical/Silent Celiac Disease

Endomysial antibodies (EMA) are a well-known hallmark of celiac disease, but some recent studies showed that the prevalence of these antibodies in clinical practice is lower than expected. The aim of our study was to determine the prevalence of antigliadin (AGA) and EMA antibodies on a consecutive s...

Ausführliche Beschreibung